Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2010
10/06/2010EP1456650B1 Gfats as modifiers of the p53 pathway and methods of use
10/06/2010EP1451193B1 Podophyllotoxins as antiproliferative agents
10/06/2010EP1421105B1 Anti-cancer cyclopenta¬g quinazoline compounds
10/06/2010EP1309569B1 N-aryl-{4-[7-(alkoxy)quinazolin-4-yl]piperazinyl}carboxamide derivatives as PDGFRs inhibitors
10/06/2010EP1220906B1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby
10/06/2010EP1131457B1 Systemic viral/ligand gene delivery system and gene therapy
10/06/2010CN1911329B Traditional Chinese medicine composition for preventing and/or adjuvant therapy of malignant tumor
10/06/2010CN1771931B Use of diterpene compound in preparing medicines with synergistic effect to chemical therapy medicines
10/06/2010CN1711074B Liposomes
10/06/2010CN1681508B Novel inhibitors of kinases
10/06/2010CN1646684B Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
10/06/2010CN1616665B Targeted liposome gene delivery
10/06/2010CN1606444B Inhibitors of human phosphatidyl-inositol 3-kinase delta
10/06/2010CN1520300B Dihydro-triterpenes in treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
10/06/2010CN101855346A PKIB and NAALADL2 for target genes of prostate cancer therapy and diagnosis
10/06/2010CN101855244A Novel antibodies
10/06/2010CN101855237A Peptide ligand directed drug delivery
10/06/2010CN101855218A Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof
10/06/2010CN101855199A Tricyclic amide compound
10/06/2010CN101854979A C-19 steroids for therapeutic uses
10/06/2010CN101854955A Mitochondria-targeted anti-tumor agents
10/06/2010CN101854952A Isoflavone formulation
10/06/2010CN101854945A Ctl inducer composition
10/06/2010CN101854924A Methods and compositions for measuring WNT activation and for treating WNT-related cancers
10/06/2010CN101854919A Compositions for the treatment of neoplastic diseases
10/06/2010CN101854915A Formulation containing cyclin-dependent kinase inhibiting compound and method of treating tumors using the same
10/06/2010CN101851294A Cell-penetrating peptide (Arg) 9 and lidamycin fusion protein (Arg) 9-LDP
10/06/2010CN101851275A Dimerized peptide
10/06/2010CN101851273A Glaucocalyxin A derivative, preparation method and application thereof
10/06/2010CN101851272A Glaucocalyxin B, derivative, preparation method and application thereof
10/06/2010CN101851271A Glaucocalyxin D derivative, preparation method and application thereof
10/06/2010CN101851266A Novel cycloartane triterpenoidsaponins and preparation method and application thereof
10/06/2010CN101851256A Ruthenium (II) porphyrin complex connected by flexible carbon chain and preparation method and application thereof
10/06/2010CN101851251A Dibutyltin (IV) complex for acyl hydrazone Schiff-base ligand and preparation method and application thereof
10/06/2010CN101851250A Organotin hydroximic acid compound, preparation method thereof and application thereof
10/06/2010CN101851241A Anti-tumor compound and preparation method and application thereof
10/06/2010CN101851237A spiro compounds, method for preparing same and application thereof
10/06/2010CN101851231A Synthesis method of novel Taxotere derivative and application thereof in preparation of anti-tumor medicine
10/06/2010CN101851220A Isoprene flavonoid compound and application thereof
10/06/2010CN101851218A 4,5-disubstituted aryl isoselenazol derivative and application thereof
10/06/2010CN101851199A Substituted piperazine N-ethyl sulfonamide derivative and preparation and application thereof
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/06/2010CN101850126A Product for preventing and/or treating prostate cancer
10/06/2010CN101850125A Application of targeted mouse APRIL small interfering RNA in medicaments for treating mouse colon cancer
10/06/2010CN101850122A Cholesterylchitosan nano carrier as well as medicament-carried nano particle and preparation method thereof
10/06/2010CN101850118A Preparation method and application in preparation of photodynamic therapy medicines of fat-soluble photosensitizer loaded on inorganic salt carrier
10/06/2010CN101850110A Novel medicinal composition and preparation method
10/06/2010CN101850107A Application of skeleton protein source polypeptide in preparing medicines for restraining invasion and transfer of colorectal cancer cells
10/06/2010CN101850106A Application of pumpkin protein in preparing medicine for treating pancreatic cancer
10/06/2010CN101850064A Chinese medicament for treating cancer
10/06/2010CN101850032A Anti-tumor traditional Chinese medicine composition and preparation method and application thereof
10/06/2010CN101850006A Chinese medicinal herb for treating breast neoplasms
10/06/2010CN101849981A Myrrh target area for treatment of gynecological tumor and preparation method and application thereof
10/06/2010CN101849978A Method for extracting polyphenol active ingredient in geranium wilfordii through high-efficiency enzyme induction
10/06/2010CN101849975A Application of moonwort extract in preparation of medicament for inhibiting tumor metastasis
10/06/2010CN101849972A Banding detection method of Cordyceps sinensis DNA fingerprint high resolution ratio
10/06/2010CN101849971A Soft capsule containing coenzyme Q10 and preparation method and application thereof
10/06/2010CN101849954A Application of compound 20 (S)-panaxoside to preparing medicament for treating benign proliferative diseases of gynaecologic reproductive system
10/06/2010CN101849934A Phosphatidylinositol-3-kinase inhibitor and application thereof
10/06/2010CN101849915A Vinorelbine stealth liposome freeze-dried powder injection and preparation method thereof
10/06/2010CN101849909A Preparation method of magnetic disodium clodronate liposome
10/06/2010CN101849907A Nanoemulsion of N-[4-(2,4 dimethoxy phenyl)-5-oxygroup-4,5-dihydro-[1,2] disulfide group-[4,3-b]-6-pyrryl]-3,5-di-trifluoromethyl benzamide and preparation method thereof
10/06/2010CN101849906A Methods for the treatment of endometriosis
10/06/2010CN101391104B New use of oncolytic adenovirus recombinant of tumour cell single-expression immunoloregulation fator GM-CSF
10/06/2010CN101361899B Traditional Chinese medicine formulation for treating lung cancer
10/06/2010CN101352434B Use of triptolide in preparing medicament for treating c-KIT tyrosine kinase related tumor
10/06/2010CN101334356B Gas sensors
10/06/2010CN101152178B Sophoridine nano liposome medicament and preparation of the same
10/06/2010CN101113163B Hla-a24-restricted cancer antigen peptides
10/06/2010CN101095670B Luteolin phospholipid complexes and method for preparing the same and application thereof
10/06/2010CN101039660B Stable pegylated interferon formulation
10/06/2010CN100999734B Application in adenovirus expression carrier of humen immunoglobulin promoter
10/05/2010US7809428 Devices for detection and therapy of atheromatous plaque
10/05/2010US7809417 Contact lens for collecting tears and detecting analytes for determining health status, ovulation detection, and diabetes screening
10/05/2010US7807805 isolated nucleic acid encoding an immunogenic peptide recognized by T lymphocytes; host cell transfected with the recombinant expression vector encoding an immunogenic protein; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
10/05/2010US7807719 4-Chloro-2-cyano-5-phenyl-penta-2E,4Z-dienoic acid 3,4-dihydroxybenzylamide, used as antiproliferative agents
10/05/2010US7807713 treatment of androgen-dependent disorders selected from prostate cancer, acne, seborrhea, hirsutism, alopecia and hidradenitis suppurativa comprising administering androgen receptor antagonists such as N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methyl-3-(naphthalen-1-ylsulfonyl)propanamide
10/05/2010US7807710 epothilone-like derivates used as anticarcinotgenic and antitumor agents
10/05/2010US7807705 [1-(3'-nitro-4'-chlorobenzenesulfonyl)-1H-indol-3-yl]-methanol, used for inducing apoptosis in unwanted rapidly proliferating cells, treating, inhibiting or delaying the onset of cancer
10/05/2010US7807689 such as 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile, used for the treatment of breast cancer and non-insulin depepndent diabetes
10/05/2010US7807683 N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
10/05/2010US7807682 Pyridyl cyanoguanidine compounds
10/05/2010US7807681 Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
10/05/2010US7807674 such as 2-[3,5-Dichloro-4-(5-isopropyl-1-methyl-6-oxo-1,6-dihydro-pyridazin-3-ylmethyl)-phenyl]-3,5-dioxo-2,3,4,5-tetrahydro-[1,2,4]triazine-6-carbonitrile, useful for the treatment of obesity, hyperlipemia, hypercholesterolemia, diabetes, fatty liver, atherosclerosis, cancer and cardiovascular disorders
10/05/2010US7807659 5-Fluoro-4-oxo-3-[1-(substituted-carbonyl)-2-piperidinecarboxamido]-pentanoic acid derivatives such as [3S/R (2S)]-5-Fluoro-4-oxo-3-[1-(2-phenyl-thiazole-4-carbonyl)-2-piperidinecarboxamido]-pentanoic acid, used for the treatment of bone disorders, inflammatory, autoimmune and degenerative diseases
10/05/2010US7807621 end capped sequence OCTAPEPTIDE; ANTITUMOR AGENT; antiproliferative agent; angiogenesis inhibitors
10/05/2010US7807441 Nucleotide sequences which code protein that induces cytotoxic T-lymphocyte immunity against weak selfproteins; antitumor agents
10/05/2010US7807179 Reoviridae virus is conjugated to a hydroxylated hydrocarbon or a polycationic polymer to reduce the clearance and immunogenicity; antiproliferative disorders
10/05/2010US7807170 Modulating an immune response in a subject by administering an effective amount of a lymphocyte differentiation factor; antiinflammatory agents
10/05/2010US7807147 Tumor therapy with high affinity laminin receptor-targeted vectors
10/05/2010US7807142 comprising interleukin-2 (IL-2); using an amino acid base sufficient to decrease aggregate formation of the polypeptide during storage of the composition, and a buffering agent ; mixture with amino acid and buffer
10/05/2010US7807133 Diagnosis, therapy of tumors; as compared to avidin, the diavidins have shown ability to increase amount of labelled biotin on target, when used in an in vitro pretargeting test using supported human tenascin, the biotinylated anti-tenascin monoclonal antibody (Mab-B), avidin/diavidin, and biotin-3H
10/05/2010CA2436233C Perylenequinones for use with immunotherapy agents
10/05/2010CA2407967C Tubulin binding ligands and corresponding prodrug constructs
10/05/2010CA2393297C Polyhydroxystilbenes as antipsoriatic agents and protein kinase inhibitors
10/05/2010CA2369595C Conjugate having a cleavable linkage for use in a liposome
09/2010
09/30/2010WO2010111713A2 N-linked glycan biosynthesis modulators
09/30/2010WO2010111671A1 Oncofetal antigen/immature laminin receptor antibodies for diagnostic and clinical applications
09/30/2010WO2010111653A2 Modulating ires-mediated translation
09/30/2010WO2010111631A1 Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds
1 ... 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 ... 2211